HEMODYNAMIC CHARACTERIZATION OF TOLERANCE TO LONG-TERM HYDRALAZINE THERAPY IN SEVERE CHRONIC HEART-FAILURE

被引:111
作者
PACKER, M
MELLER, J
MEDINA, N
YUSHAK, M
GORLIN, R
机构
关键词
D O I
10.1056/NEJM198201143060201
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:57 / 62
页数:6
相关论文
共 30 条
[1]   ORAL HYDRALAZINE IN CHRONIC HEART-FAILURE - SUSTAINED BENEFICIAL HEMODYNAMIC-EFFECTS [J].
CHATTERJEE, K ;
PORTS, TA ;
BRUNDAGE, BH ;
MASSIE, B ;
HOLLY, AN ;
PARMLEY, WW .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) :600-604
[2]   MECHANISMS AND IMPLICATIONS OF VASODILATOR TOLERANCE IN THE TREATMENT OF CONGESTIVE HEART-FAILURE [J].
COLUCCI, WS ;
WILLIAMS, GH ;
ALEXANDER, RW ;
BRAUNWALD, E .
AMERICAN JOURNAL OF MEDICINE, 1981, 71 (01) :89-99
[3]   DECREASED LYMPHOCYTE BETA-ADRENERGIC-RECEPTOR DENSITY IN PATIENTS WITH HEART-FAILURE AND TOLERANCE TO THE BETA-ADRENERGIC AGONIST PIRBUTEROL [J].
COLUCCI, WS ;
ALEXANDER, RW ;
WILLIAMS, GH ;
RUDE, RE ;
HOLMAN, BL ;
KONSTAM, MA ;
WYNNE, J ;
MUDGE, GH ;
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (04) :185-190
[4]   T TESTS AND INTERVALS FOR COMPARISONS SUGGESTED BY DATA [J].
DUNCAN, DB .
BIOMETRICS, 1975, 31 (02) :339-359
[5]   DEPENDENCE OF ARTERIAL-PRESSURE ON INTRAVASCULAR VOLUME IN TREATED HYPERTENSIVE PATIENTS [J].
DUSTAN, HP ;
BRAVO, EL ;
TARAZI, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (16) :861-+
[6]  
FINNERTY FA, 1980, CIRC RES S1, V27, P71
[7]   HYDRALAZINE IN THE MANAGEMENT OF LEFT-VENTRICULAR FAILURE [J].
FITCHETT, DH ;
MARINNETO, JA ;
OAKLEY, CM ;
GOODWIN, JF .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (02) :303-309
[8]  
FRANCIOSA JA, 1980, CIRCULATION, V62, P260
[9]  
HARRIS E, 1954, LANCET, V1, P429
[10]   REDUCED DRUG ELIMINATION IN CONGESTIVE HEART-FAILURE - STUDIES USING AMINOPYRINE AS A MODEL DRUG [J].
HEPNER, GW ;
VESELL, ES ;
TANTUM, KR .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (02) :271-276